IDSA and HIVMA Support BIO Preparedness Workforce Act

IDSA and HIVMA applaud the bipartisan introduction of the Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act by Sens. Tammy Baldwin (D-WI) and Susan Collins (R-ME).

IDSA Honors 199 Distinguished Clinicians, Scientists with FIDSA Designation

IDSA, the nation’s leading infectious diseases professional society, recognizes the distinguished clinicians and scientists from the United States and around the world who were elected this year to be Fellows of IDSA.

Statement on OSHA and CMS COVID Vaccine Mandates for Employers and Employees

IDSA supports COVID-19 vaccine mandates announced by the Occupational Safety and Health Administration for large private employers and the Centers for Medicare and Medicaid Services for employees at Medicare and Medicaid-participating health care facilities.

IDSA Creates New Committee to Focus on Inclusion, Diversity, Access and Equity

In recognition of the importance of inclusion, diversity, access and equity as long-term priorities and core values for IDSA, the Society’s Board of Directors recently approved the creation of a permanent IDA&E Committee.

New Review Article Outlines Potential of SARS-CoV-2 Genetic Sequencing in Patient Care

The rise of more transmissible variants of SARS-CoV-2 has spurred growing interest in harnessing information about the genetic sequences of these variants to help treat patients.

IDSA and PIDS Support Authorization of Pediatric COVID-19 Vaccine

To date, 6 million children have been diagnosed with COVID-19. The more than 28 million children who will be eligible to be vaccinated against COVID-19 with this authorization comprise a larger portion of the population than the already eligible 12-17-year-old cohort.

IDSA Response to CDC’s Recommendation for People Previously Infected with COVID-19 to get Vaccinated

The Infectious Diseases Society of America strongly supports the CDC’s recommendation that unvaccinated people previously infected with the virus that causes COVID-19 get vaccinated as soon as possible after they have fully recovered.

Response to ACIP Recommendation for Heterologous Boosters

The Infectious Diseases Society of America supports the CDC Advisory Committee on Immunization Practice’s unanimous recommendation to allow “mix-and-match”—or heterologous—COVID-19 booster shots for at-risk populations. 

IDSA and HIVMA Support BIO Preparedness Workforce Act

IDSA and HIVMA applaud the bipartisan introduction of the Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act by Reps. Lori Trahan (D-MA) and David McKinley (R-WV), H.R. 5602, and its inclusion in an Oct. 26 Energy and Commerce Health Subcommittee hearing. 

IDSA Dismissed from Lawsuit Judge Rules Lawsuit Against IDSA Baseless

In legal rulings issued on Sept. 1 and Sept. 20, a federal judge in Texas dismissed all claims a group of Lyme disease patients had brought against the Infectious Diseases Society of America.  

Drug-resistant Infections Led to $1.9 Billion in Health Care Costs, More Than 10,000 Deaths Among Older Adults in One Year

Infections caused by bacteria resistant to multiple antibiotics led to $1.9 billion in health care costs, more than 400,000 days in the hospital and more than 10,000 deaths among older adults across the U.S. in 2017, according to a new study published today in Clinical Infectious Diseases.

IDSA Awarded Second CDC Grant for Continued COVID-19 Support for Health Care Workers

IDSA and the Centers for Disease Control and Prevention have announced they will continue their collaborative effort to support frontline health care professionals caring for patients with COVID-19.